TrialNature medicine2026
Oral splicing modulator branaplam in Huntington's disease: a phase 2 randomized controlled trial.
Beth Borowsky et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
TrialNature medicine2026
Beth Borowsky et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.